Dr. Tashko’s infographic highlighting hypoparathyroidism depicts a simplified human figure with an orange parathyroid overlay on the neck. Surrounding icons illustrate low calcium levels (droplet with downward arrow), bone impact, and neuromuscular symptoms (glowing nerve cell). The clean, pastel-toned design emphasizes the endocrine and systemic consequences of parathyroid hormone deficiency in a visually accessible format.

Hypoparathyroidism is a rare but important endocrine condition. It affects calcium balance in the body and can lead to a wide range of symptoms—from subtle to severe. While many people associate calcium only with bones, it also plays a crucial role in nerve function, muscle control, and overall cellular health.

When parathyroid glands underperform, the ripple effects touch multiple systems. But with early detection, individualized care, and smart management, patients can regain balance and avoid complications. Let’s explore the basics, the deeper physiology, and how personalized endocrine care can make all the difference.

What Is Hypoparathyroidism?

Hypoparathyroidism occurs when the parathyroid glands produce insufficient parathyroid hormone (PTH). Located behind the thyroid, these four tiny glands help regulate calcium and phosphorus levels through PTH secretion. Without enough PTH, blood calcium drops while phosphorus rises—setting off neuromuscular, skeletal, and even cognitive symptoms.

The condition can be:

  • Acquired, most commonly after thyroid or parathyroid surgery
  • Autoimmune, where the body mistakenly targets parathyroid tissue
  • Genetic, due to inherited defects in parathyroid development or signaling
  • Transient, especially in newborns or after certain viral infections

Parathyroid Hormone: Small Molecule, Big Role

PTH maintains calcium balance by acting on:

  • Bones: releasing calcium into the blood
  • Kidneys: reducing calcium loss and activating vitamin D
  • Intestines: indirectly increasing calcium absorption via activated vitamin D (calcitriol)

When PTH is deficient, these mechanisms falter. Calcium levels fall, leading to symptoms like:

  • Tingling in the fingers or around the mouth
  • Muscle cramps or twitching
  • Seizures in severe cases
  • Mood changes, brain fog, or depression
  • Brittle nails or hair loss over time

Causes of Hypoparathyroidism

CauseDescription
Post-surgicalMost common form—occurs after thyroid or neck surgery
AutoimmuneMay occur alone or as part of polyglandular autoimmune syndromes
GeneticIncludes conditions like DiGeorge syndrome or familial isolated hypoparathyroidism
IdiopathicNo known cause, but PTH remains low with low calcium
InfiltrativeIron or copper overload—seen in hemochromatosis or Wilson’s disease—can damage parathyroid tissue.
FunctionalTemporary suppression, as seen in hungry bone syndrome after surgery

In adults, post-surgical hypoparathyroidism is the leading cause, especially after removal of the thyroid for cancer or Graves’ disease. In such cases, one or more parathyroid glands may be injured or unintentionally removed.

Diagnosis: More Than Just Calcium

Accurate diagnosis hinges on a few key labs:

  • Low serum calcium
  • Low or inappropriately normal PTH
  • High serum phosphate
  • Low urinary calcium excretion (in some cases)
Dr. Tashko’s chart showing hypoparathyroidism features two graphs illustrating a drop in parathyroid hormone (PTH) and calcium levels. The left bar graph highlights low PTH, while the right line graph shows fluctuating and declining calcium. An orange downward arrow emphasizes the hormonal deficiency’s effect on calcium regulation, reinforcing the physiological connection in this endocrine disorder.

Parathyroid specialists may also check for magnesium levels, vitamin D status, and urinary calcium to fine-tune management. In chronic cases, DEXA scans may reveal low bone turnover or overly dense bones.

Treatment: Correcting the Imbalance

Traditional treatment aims to restore calcium levels and reduce symptoms:

  • Calcium supplements, often divided throughout the day
  • Active vitamin D (calcitriol) to enhance absorption
  • Magnesium supplementation, when deficient
  • Thiazide diuretics in select patients to reduce urinary calcium loss

In some cases of difficult-to-control disease, PTH replacement therapy may be used under expert supervision. Available options include:

  • Palopegteriparatide, a long-acting prodrug that converts into PTH (1-34) after administration. It was recently FDA-approved for adults with hypoparathyroidism.
  • Teriparatide (PTH 1-34), a recombinant form approved for osteoporosis, may be used off-label in select cases.
  • Recombinant human PTH (1-84), previously available as Natpara, is currently off-market.

These options are generally reserved for patients who struggle with symptom control or complications from standard calcium and vitamin D therapy.

However, treatment is not just about normalizing blood calcium. Patients often experience fluctuations in symptoms that don’t neatly correlate with lab values. This highlights the importance of thoughtful care from multiple angles.

Complications to Monitor

Without proper care, hypoparathyroidism can lead to:

  • Calcifications in the brain (basal ganglia), visible on imaging
  • Kidney stones or nephrocalcinosis, from too much calcium excretion
  • Cataracts
  • Arrhythmias or heart dysfunction, due to low calcium
  • Cognitive decline or psychiatric symptoms

These risks make regular follow-up and comprehensive management essential—even when symptoms seem stable.

Why Holistic, Individualized Care Matters

Managing hypoparathyroidism requires more than pill-counting. A thoughtful approach considers:

  • Nutrient interactions (e.g., magnesium, phosphorus, vitamin D)
  • Kidney health and urine calcium excretion
  • Cognitive and emotional symptoms, not just lab numbers
  • Patient lifestyle, diet, and activity
  • Other endocrine conditions (e.g., thyroid, adrenal, or autoimmune overlap)

At our practice in Montgomery County, Maryland, we provide comprehensive endocrine care with a focus on long-term stability and patient well-being. For patients outside the area, we also offer virtual consultations and thoughtful second-opinion guidance when appropriate.

Summary Table: Hypoparathyroidism at a Glance

FeatureDescription
Core ProblemLow PTH → low calcium, high phosphorus
Main SymptomsNumbness, cramps, brain fog, seizures
Common CausesSurgery, autoimmune, genetic, idiopathic
Labs↓Ca, ↑P, ↓PTH
First-Line TreatmentCalcium + active vitamin D
Advanced TherapiesPTH replacement, thiazides
RisksKidney stones, brain calcification, mood changes
Care ApproachPersonalized, holistic, calcium-phosphate-magnesium balance

Final Thoughts

Calcium isn’t just about bones—it’s a fundamental element in how we move, think, and feel. The parathyroid glands, though tiny, play a huge role in keeping that calcium in check. When their signals go silent, symptoms can be confusing, misattributed, or long ignored.

That’s why it’s important to view hypoparathyroidism through a broader lens. Individualized care helps avoid overcorrection, supports mental health, and prevents long-term complications. A smart strategy looks not only at numbers but also at the human experience behind them.

With comprehensive care and ongoing partnership, patients can feel steady, supported, and symptom-free.

Dr. Tashko

  1. Hypoparathyroidism: Diagnosis, Management and Emerging Therapies. Khan S, Khan AA. Nature Reviews. Endocrinology. 2025;21(6):360-374. doi:10.1038/s41574-024-01075-8.
  2. Hypoparathyroidism. Gafni RI, Collins MT. The New England Journal of Medicine. 2019;380(18):1738-1747. doi:10.1056/NEJMcp1800213.
  3. Hypoparathyroidism: Genetics and Diagnosis. Mannstadt M, Cianferotti L, Gafni RI, et al. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research. 2022;37(12):2615-2629. doi:10.1002/jbmr.4667.
  4. Presentation of Hypoparathyroidism: Etiologies and Clinical Features.  Shoback DM, Bilezikian JP, Costa AG, et al. The Journal of Clinical Endocrinology and Metabolism. 2016;101(6):2300-12. doi:10.1210/jc.2015-3909.
  5. Epidemiology and Diagnosis of Hypoparathyroidism. Clarke BL, Brown EM, Collins MT, et al. The Journal of Clinical Endocrinology and Metabolism. 2016;101(6):2284-99. doi:10.1210/jc.2015-3908.
  6. Hypoparathyroidism. Mannstadt M, Bilezikian JP, Thakker RV, et al. Nature Reviews. Disease Primers. 2017;3:17055. doi:10.1038/nrdp.2017.55.
  7. Management of Hypoparathyroidism. Khan AA, Guyatt G, Ali DS, et al. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research. 2022;37(12):2663-2677. doi:10.1002/jbmr.4716.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.